NM_000059.4(BRCA2):c.6017G>C (p.Ser2006Thr) AND not specified

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jan 5, 2017
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000239063.13

Allele description [Variation Report for NM_000059.4(BRCA2):c.6017G>C (p.Ser2006Thr)]

NM_000059.4(BRCA2):c.6017G>C (p.Ser2006Thr)

Gene:

BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

13q13.1

Genomic location:

Preferred name:

NM_000059.4(BRCA2):c.6017G>C (p.Ser2006Thr)

HGVS:

NC_000013.11:g.32340372G>C
NG_012772.3:g.29893G>C
NM_000059.4:c.6017G>CMANE SELECT
NP_000050.2:p.Ser2006Thr
NP_000050.3:p.Ser2006Thr
LRG_293t1:c.6017G>C
LRG_293:g.29893G>C
LRG_293p1:p.Ser2006Thr
NC_000013.10:g.32914509G>C
NM_000059.3:c.6017G>C

Protein change:

S2006T

Links:

dbSNP: rs144784912

NCBI 1000 Genomes Browser:

rs144784912

Molecular consequence:

NM_000059.4:c.6017G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000296556	Quest Diagnostics Nichols Institute San Juan Capistrano	criteria provided, single submitter (Quest Diagnostics criteria)	Uncertain significance (Jan 5, 2017)	germline	clinical testing	PubMed (3) [See all records that cite these PMIDs] 21671020, 26467025, 26295337

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000296556

Quest Diagnostics Nichols Institute San Juan Capistrano

criteria provided, single submitter

(Quest Diagnostics criteria)

Uncertain significance
(Jan 5, 2017)

germline

clinical testing

PubMed (3)
[See all records that cite these PMIDs]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Effect of the overexpression of BRCA2 unclassified missense variants on spontaneous homologous recombination in human cells.

Balia C, Galli A, Caligo MA.

Breast Cancer Res Treat. 2011 Oct;129(3):1001-9. doi: 10.1007/s10549-011-1607-y. Epub 2011 Jun 14.

PubMed [citation]

PMID:: 21671020

A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian Disorders.

Karbassi I, Maston GA, Love A, DiVincenzo C, Braastad CD, Elzinga CD, Bright AR, Previte D, Zhang K, Rowland CM, McCarthy M, Lapierre JL, Dubois F, Medeiros KA, Batish SD, Jones J, Liaquat K, Hoffman CA, Jaremko M, Wang Z, Sun W, Buller-Burckle A, et al.

Hum Mutat. 2016 Jan;37(1):127-34. doi: 10.1002/humu.22918. Epub 2015 Oct 29.

PubMed [citation]

PMID:: 26467025
PMCID:: PMC4737317

See all PubMed Citations (3)

Details of each submission

From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV000296556.3

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (3)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Nov 10, 2024

ClinVar

Relating variation to medicine